Speed Key For Antiviral To Work: Cowling
"); jQuery("#212 h3").html("

"); });
2022-03-16 HKT 09:09
A leading epidemiologist said on Wednesday that the SAR must ensure that a groundbreaking anti-viral treatment gets to Covid-19 patients as quickly as possible if it's to have the maximum effect in reducing hospital admissions and deaths.
The Hospital Authority is rolling out Paxlovid for vulnerable Covid patients from Wednesday, with those showing mild symptoms given the pill at designated clinics, care homes and public hospitals.
Speaking on RTHK's Hong Kong Today programme, Benjamin Cowling from the University of Hong Kong's School of Public Health, said the treatment could substantially reduce severe cases.
"It looks very promising from the clinical trials," he told RTHK's Vicky Wong. "If it's given early, as early as possible, there's an indication that it could substantially reduce the risk of severe disease."
"Now if it's given to people after a few days of illness, after a week of illness, and they go to the hospital in a serious condition already, it won't work so well. It really has to be given very, very early."
The SAR has purchased an undisclosed number of Paxlovid pills from its manufacturer, Pfizer. It's also bought supplies of another antiviral, Molnupiravir, which has shown lower effectiveness in trials but which may be suitable for patients who can't receive Paxlovid, such as those with kidney problems.
Cowling said it's not time to relax social distancing measures despite falling case numbers.
"Thankfully the case numbers are coming down. They're coming down slowly, but I think they will continue to come down. We know there've already been a lot of infections. There's a large number of confirmed cases and, of course, many more infections that were not confirmed," he said.
"So we know that this epidemic is in decline, the numbers will continue to go down to a low level but not quite yet, so I don't think it's a good time yet to relax the measures that we have in place. Let's wait until the numbers get a little bit lower."
Hong Kong reported 27,765 new cases on Tuesday.
Circle CEO Says China Could Launch Yuan Stablecoin In 3 To 5 Years As Trade Grows
Circle CEO Jeremy Allaire predicts that China could roll out a yuan stablecoin within three to five years to expand the... Read more
Naver IPO Timeline Set As Dunamu Merger Targets Nasdaq Debut
Preparations for a Naver IPO are underway following an agreement between Naver Financial and cryptocurrency exchange op... Read more
TransUnion Urges Lenders To Rethink Credit Risk For Gig Workers In Hong Kong
TransUnion is urging lenders to update their risk assessment models, revealing that gig workers in Hong Kong exhibit st... Read more
Citi And Endowus Roll Out HK$4,000 Wealth-Linked Credit Card Campaign
Citi and digital wealth platform Endowus have launched a joint credit card promotion in Hong Kong, expanding the Citi E... Read more
Aspire Secures SFC License In Hong Kong To Launch SME Yield Product
Singapore-headquartered fintech Aspire has secured three financial licenses from the Securities and Futures Commission ... Read more
Why Stablecoins May Become The Backbone Of 24/7 Global Trade
Stablecoin transaction volumes surged 72% in 2025, reaching a record US$33 trillion and signalling growing institutiona... Read more